Loss of MACROD2 drives radioresistance but not cisplatin resistance in HPV-positive head and neck cancer.
Dawson A, Karimi AH, Shaikh MH, Gazala W, Zeng PYF, Ryan SEB, Pan H, Khan H, Cecchini M, Mendez A, Palma DA, Mymryk JS, Barrett JW, Nichols AC.
Dawson A, et al. Among authors: ryan seb.
Oral Oncol. 2024 Dec;159:107061. doi: 10.1016/j.oraloncology.2024.107061. Epub 2024 Oct 1.
Oral Oncol. 2024.
PMID: 39357386
Free article.